Title : Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial.

Pub. Date : 2022 Feb

PMID : 35040210






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Besides, a considerable difference was observed between the nano-curcumin and control groups in the expression of IFN-gamma (p = 0.001), IL-1beta (p = 0.0002), and IL-6 (p = 0.008). Curcumin interleukin 1 alpha Homo sapiens
2 In addition, there was a significant difference between the nano-curcumin and control groups in the serum levels of IL-1beta (p = 0.042). Curcumin interleukin 1 alpha Homo sapiens